PropThink: QCOR Posts Positive Script Trends For Acthar; Analyst Comes Back Around

[ACN Newswire] – By David MoskowitzQuestcor Pharmaceuticals (NASDAQ:QCOR) announced prescription trend data this morning for its primary revenue driver, H.P. Acthar Gel (Acthar), and the news is positive, sending the shares … more

View todays social media effects on QCOR

View the latest stocks trending across Twitter. Click to view dashboard